managed dsip ii equity strategy Private Due Diligence: What You Need to Know A surprising deal from Vertex
A surprising deal from Vertex Pharmaceuticals adds to Big Pharma's acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked A technical guide to ESG integration in equity investing PRI Navigating the Divide: Active vs. Passive Strategies in Today's Equity Markets NewEdge Wealth 10 Private Equity Strategies for Value Creation Reimagining the 60 40 Portfolio with Private Equity Secondaries
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

